Philadelphia Multiple Myeloma Networking Group (PMMNG)

02/28/2025

In this HealthTree University video lesson you will learn why your treatment stops work leading to relapse.

Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversityCreate a free account to track your progress, bookmark less...

02/15/2025

Did you know there are 2 types of relapses in myeloma? In this HealthTree University video both types of relapses are explained by leading myeloma specialists as well as when treatment should resume. .

Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversityCreate a free account to track your progress, bookmark less...

08/10/2023

https://www.prnewswire.com/news-releases/us-fda-approves-talvey-talquetamab-tgvs-a-first-in-class-bispecific-therapy-for-the-treatment-of-patients-with-heavily-pretreated-multiple-myeloma-301897786.html

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has granted...

07/12/2023

The role of imaging in MRD testing.

Learn about how imaging plays a role in MRD testing.Get exclusive access to the latest content as soon as it's filmed at https://www.healthtree.org/myeloma/u...

07/08/2023

To all of the PMMNG family and friends,

Welcome summer!

Our next monthly PMMNG meeting will be held Saturday, July 8, 2023 from 1:30-3:00 PM ET. The meeting will be conducted via Zoom. See below for the link.

We will be breaking out into small groups at the beginning of the meeting, followed by the presentation by Dr Faiman. You will have an opportunity to address specific issues and questions in the small groups.

Beth Faiman will be presenting on the topic of “Updates in Bone Health” including updates in medications, timing, and how to optimize bone health in myeloma.

If you are new to the group, contact Barbara Falkowitz (barbarafalkowitz@gmail.com) to receive the meeting link.

07/08/2023

An oldie, but goodie - All About Dexamethasone

Get exclusive access to the latest content as soon as it's filmed at https://www.healthtree.org/myeloma/university HealthTree University for Multiple Myeloma...

07/06/2023

MRD testing, or minimal residual disease testing, is a diagnostic technique used to detect and monitor trace amounts of myeloma cancer cells remaining in a patient's body after treatment.

By identifying and monitoring these minimal residual disease levels, clinicians can assess treatment response, predict disease relapse, and make informed decisions regarding further therapy.

Learn about MRD and what it means to be MRD negative and access the whole MRD testing course at HealthTree University.

Minimal residual disease testing, is a diagnostic technique used to detect and monitor trace amounts of cancer cells in a patient's body after treatment.

06/05/2023

https://youtu.be/1fpzDPEZse8

Interview with Hans Lee, MD from the Anderson Cancer Center at ASCO 2023. Filmed June 3rd, 2023.The HealthTree Foundation for Multiple Myeloma brings informa...

05/27/2023

Besides BCMA, what other new targets are being explored in myeloma? https://youtu.be/ZtlgZgyTj6g

Learn about other cell targets and how doctors and physicians are exploring their uses in CAR-T cell therapy.Get exclusive access to the latest content as so...

05/17/2023

FYI

Myeloma/multiple myeloma (MM) (Copay) now open at Leukemia and Lymphoma Society.

Please Note: Funding is limited, and disease fund statuses may change quickly. Assistance is awarded on a first-come, first-served basis and subject to each foundation’s criteria. Contact the listed foundation to learn more.

04/22/2023

Cindy Chmielewski shares her myeloma story and how service and progress in myeloma brings hope.pe.

04/14/2023

Response- remission… What does it mean?

HealthTree University, provided by the HealthTree Foundation, offers a comprehensive online multiple myeloma curriculum with lessons, quizzes and course disc...